| Bioactivity | AChE/BChE-IN-19 (Compound 12) is a nicotinic hydrazide derivative. AChE/BChE-IN-19 (Compound 12) is a inhibitor of AChE (IC50 = 21.45 nM) and BChE (IC50 =18.42 nM). AChE/BChE-IN-19 (Compound 12) can be used in Alzheimer's disease research[1]. |
| Formula | C26H22N4O3 |
| Molar Mass | 438.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Resiţ Çakmak, et al. Synthesis of Novel Hydrazide−Hydrazone Compounds and In Vitro and In Silico Investigation of Their Biological Activities against AChE, BChE, and hCA I and II. ACS Omega. 2024, 9, 18, 20030–20041 |